We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

QIAGEN Launches QuantiTect® Whole Transcriptome Kit

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

QIAGEN has released the QuantiTect® Whole Transcriptome Kit that delivers high and reproducible cDNA yields from limited amounts of RNA by whole transcriptome amplification (WTA). The cDNA is intended for use in real-time PCR and contains uniformly amplified targets to ensure reliable gene expression analysis.

Comprehensive gene expression analysis of rare samples is often not possible due to low RNA amounts. The QuantiTect Whole Transcriptome Kit overcomes this by amplifying all mRNA transcripts in a sample. From as little as 1 ng RNA or RNA corresponding to about 50 cells, up to 40 µg cDNA is generated for unlimited real-time PCR analysis and archiving.

The Company claims that highly uniform amplification of all mRNA transcripts is achieved with the QuantiTect Whole Transcriptome Kit. Both the 5' and 3' regions of each transcript are equally amplified, and the relative abundance of each transcript is preserved after amplification. This ensures unbiased results in subsequent gene expression analysis.

Whole transcriptome amplification is performed in a streamlined 3-step protocol. RNA is first reverse transcribed into cDNA and then ligated before being amplified using proven REPLI-g® technology. The QuantiTect Whole Transcriptome Kit contains all the necessary enzymes and buffers for the process, and does not require reaction optimization by the user.